qed biomedical can help investors identify the risks in early biotechnology innovations; providing optimal decision making.
Before investment are you sure?
• The preclinical evidence is reproducible?
• The models/tissue samples represent the disease?
• There is an in depth biological understanding of the target?
• You know the evidence gaps and evidence strengths?
We provide transparent summaries of novel technologies, indicating strengths and weaknesses in the evidence.
Importantly your decision will be evidence-based and unbiased.